Cargando…
ΔNp73, TAp73 and Δ133p53 Extracellular Vesicle Cargo as Early Diagnosis Markers in Colorectal Cancer
SIMPLE SUMMARY: The survival of colorectal cancer patients largely relies on the stage at diagnosis. The identification of early and non-invasive biomarkers to be used in screening programs for the diagnosis of the disease at the premalignant stage is mandatory. The aim of this study is to validate...
Autores principales: | Rodríguez-Cobos, Javier, Viñal, David, Poves, Carmen, Fernández-Aceñero, María J., Peinado, Héctor, Pastor-Morate, Daniel, Prieto, Mª Isabel, Barderas, Rodrigo, Rodríguez-Salas, Nuria, Domínguez, Gemma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124369/ https://www.ncbi.nlm.nih.gov/pubmed/34066954 http://dx.doi.org/10.3390/cancers13092240 |
Ejemplares similares
-
Relative expression of TAp73 and ΔNp73 isoforms
por: Conforti, Franco, et al.
Publicado: (2012) -
In‐depth proteomics characterization of ∆Np73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer
por: Garranzo‐Asensio, María, et al.
Publicado: (2022) -
DEC1 Coordinates with HDAC8 to Differentially Regulate TAp73 and ΔNp73 Expression
por: Qian, Yingjuan, et al.
Publicado: (2014) -
The specific seroreactivity to ∆Np73 isoforms shows higher diagnostic ability in colorectal cancer patients than the canonical p73 protein
por: Garranzo-Asensio, María, et al.
Publicado: (2019) -
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
por: Zaika, Alex I., et al.
Publicado: (2002)